Hanwha Solutions (009830)
Korea Stock Exchange · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 28,450.00 |
|---|---|
| 52-week range | 22,000.00 – 56,415.71 |
| Return, 1 month / 3 months | −2.6% / −5.2% |
| Return, 1 year / 3 years | −1.3% / +10.7% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 89.7% |
| Worst drawdown (1 year) | -58.9% |
| Average daily value traded | 109,875.23M KRW |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hanwha Solutions is a Korean industrial company with operations in chemicals and renewable energy. It produces petrochemical materials such as polyvinyl chloride and caustic soda for industrial customers, and through its solar business it manufactures photovoltaic cells and modules for power projects and utilities. The company also runs a advanced materials and machinery operations. It is based in Seoul, Korea, and serves construction, manufacturing and energy markets in Korea and abroad.
Hanwha Solutions trades under the code 009830 on the Korea Stock Exchange in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hanwha Solutions (009830) trades on the Korea Stock Exchange in Korea. It last closed at KRW 28,450.00 on 23 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 592 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.3% and over the last three months it fell 5.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 36 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -19.9% | ||
| From 52-week high | -48.9% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.2% | ||
| 6-month return | -36.1% | ||
| 12-month return, skipping the last month | 1.3% | ||
| Stability (higher is calmer) | 17 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 89.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -58.9% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 109,875.23M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −9.5% |
|---|---|
| 1 month | −2.6% |
| 3 months | −5.2% |
| 6 months | −36.1% |
| 1 year | −1.3% |
| 3 years | +10.7% |
| 5 years | −35.3% |
Signals
| 50-day / 200-day average | 32,147.00 / 35,530.45 |
|---|---|
| Golden / death cross (60 days) | Death, 57 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2,377.78 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Dec 2024 | KRW 262.0434 |
| 27 Dec 2023 | KRW 262.0434 |
| 29 Dec 2020 | KRW 174.2207 |
| 27 Dec 2019 | KRW 169.3406 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.